Recruitment Complete
Sponsor ID
20120363
Observational study to estimate the effectiveness of biologics when treating plaque psoriasis
Study Details
To estimate the real-world effectiveness of approved biologics in subjects with moderate-to-severe plaque psoriasis who are either starting or switching biologic medication.
Protocol Summary
Primary Outcome Measures
PASI100
Timeframe: 6 months
Secondary Outcome Measures
PASI100 (or sPASI=0)
Timeframe: 12 months
PASI100 (or sPASI=0)
Timeframe: 6 months and 12 months
sPGA=0
Timeframe: 6 months and 12 months
Psoriasis Symptom Inventory (PSI) responders
Timeframe: 6 months and 12 months
sPGA=0 or 1
Timeframe: 6 months and 12 months
PSI=0
Timeframe: 6 months and 12 months
Dermatology Life Quality Index (DLQI) =0
Timeframe: 6 months and 12 months
Static Patient Global Assessment (sPtGA)
Timeframe: 6 months and 12 months
Percent PASI improvement (or sPASI scores)
Timeframe: 6 months and 12 months
Locations
Location
Research Site
Ancona, Italy, 60126
Status
Recruiting
Location
Research Site
Bergamo, Italy, 24128
Status
Recruiting
Location
Research Site
Carmel, IN, United States, 46032
Status
Recruiting
Location
Research Site
Clarkston, MI, United States, 48346
Status
Recruiting
Location
Research Site
Burbank, CA, United States, 91505
Status
Recruiting
Location
Research Site
Gahanna, OH, United States, 43230
Status
Recruiting
Showing {first} - {last} of {total} Results